Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
18m agoVornado Realty Trust to Purchase 49% Interest in Park Avenue Plaza from Closer Properties
18m agoBain Capital Specialty Finance, Inc. Schedules Earnings Release for the First Quarter Ended March 31, 2026
18m agoStoneridge's MirrorEye® Camera Monitor System Continues Strong Momentum, Achieving Record Global Sales and Production Milestones
18m agoAtico Mining Produces 2.09 Million Pounds of Cu and 2,108 Ounces of Au in First Quarter 2026
18m agoMarkel Group reports 2026 first quarter results

Arovella Therapeutics Ltd

About

Arovella Therapeutics Ltd (AU:ALA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 1 2026
CLDN18.2 CAR iNKT Cell Preclinical Data Update
Feb 19 2026
Half Year Report and Appendix 4D
Jan 29 2026
ALA's IND FOR ALA-101 ACCEPTED BY THE U.S.FDA
Jan 23 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 28 2025
Positive FDA Type D Meeting Outcome

Financials

Revenue
A$3.21 M
Market Cap
A$83.3 M
EPS
-0.01

Community Chat

Ask AI

6ix6ixAIEvents